Transthyretin
1 paper
- Humans1
Latest
18 in 12 monthsCardiology and Therapy
Neurologic Stability During Tafamidis Treatment in Transthyretin Amyloidosis with a Mixed Phenotype: A Multicenter Real-World Study
Cohort study of 67 peopleInterventions
Annual Review of Pharmacology and Toxicology
Small Interfering RNA in Cardiovascular Disease: A New Frontier in Precision Medicine
ReviewCardiovascular disease
PLOS One
Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study
Non-randomised trial in 7 peopleDapagliflozin
European Heart Journal Cardiovascular Imaging
Prospective Systematic Screening for Transthyretin Amyloid Cardiomyopathy in Cardiology Inpatients With Left Ventricular Hypertrophy: the IMPACT Study
Cohort study of 400 peopleCardiomyopathy
Cardiology and Therapy
Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy
Cohort study of 1,924 peopleInterventions
Amyloid
Frailty is a mortality risk factor in tafamidis-treated patients with transthyretin cardiac amyloidosis
Cohort study of 410 peopleCardiac amyloidosis
JAMA
Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy
Cohort study of 44,123 peopleBiomarkers
The Journal of Hand Surgery, European Volume
Screening for amyloidosis in trigger finger release and Dupuytren's fasciectomy
Cohort study in peopleCardiac amyloidosis
Journal of Hand Surgery Global Online
Development of a Three-Source Convergent Risk Assessment Tool for Amyloidosis Screening in Carpal Tunnel Syndrome Patients
Cohort study of 800,662 peopleCardiac amyloidosis